With everything though, there is a season so we say, thank goodness for spring. March came in very strong with a significant referral flow and a marked improvement in volume, allowing us to finish the quarter in very strong fashion.
Net revenue increased a little less than 5% from the comparable 2009 quarter with more than a $3 per visit increase in net rate per visit. Also in the quarter in March, we closed a very nice, five location facility in the east forming a partnership with a great group, who is already focused on expanding into several additional locations.
Overall development activity has improved significantly since last year. We've a number of active discussions and our organic activity has picked up as a result of the adjustments that we have made in our advertising in social media events and publications.
To date, we have approximately a dozen approved, although not all yet opened sites so far that we'll roll in at various points this year. And that excludes our acquisition. Also in our results this quarter was a sale of a five clinic Texas joint venture, which produced a pre-tax gain of approximately $578,000 or about $0.03 in EPS for the quarter. This helped to offset the $0.05 impact from the weather and the $0.01 expense associated with closing our first quarter acquisition that one expense under the new accounting rules effective this year.Volumes have been solid for the past two months and we expect to continue to make progress in the plans discussed in our shareholder letter, including driving additional volume through our Fit-to-Work initiatives, as well as growing our company organically and through acquisitions. With that, I'd like to ask Larry to review our financial performance in greater detail before we open it up for questions. Larry McAfee Thanks, Chris. Net income for the quarter ended March 31 was $3.2 million or $0.27 per share as compared to $2.8 million or $0.23 per share in the first quarter of 2009. As Chris mentioned, included in the recent period is an after-tax gain of $0.03 per share related to the sale of an interest -- a joint-venture interest. Additionally, the company incurred legal costs of approximately $0.01 per share in conjunction with the acquisition.